🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
* To assess the safety of repeated iCo-007 intravitreal injections in treat...
Status
Terminated
Location
Stanley M Truhlsen Eye Institute
Start Date
2012-02
Trial ID
NCT01565148
Treatments Being Tested
The purpose of this first-in-human study is to evaluate the safety, pharmac...
Status
Completed
Location
Opthea Investigative Site
Start Date
2015-07
Trial ID
NCT02543229
Central and branch retinal vein occlusions are major causes of visual loss....
Status
Completed
Location
Wilmer Eye Institute
Start Date
2006-01
Trial ID
NCT00407355
Treatments Being Tested
This study is conducted in 3 stages. Stage 1 is an open-label, dose-escalat...
Status
Completed
Location
Multiple Locations
Start Date
2011-09-01
Trial ID
NCT01397409
Treatments Being Tested
The purpose of this study is to determine the effect of ranibizumab for the...
Status
Terminated
Location
Seoul National University Bundang Hospital
Start Date
2013-01
Trial ID
NCT01795209
Treatments Being Tested
This study is designed as an exploratory study to assess safety and efficac...
Status
Completed
Location
University Eye Hospital
Start Date
2014-08
Trial ID
NCT02134457
Treatments Being Tested
This is a phase III, multicenter, randomized double-blinded clinical trial ...
Status
Recruiting
Location
Hospital Universitario de Canarias
Start Date
2022-11-18
Trial ID
NCT06952452
Treatments Being Tested
This Phase I/II study will investigate the safety and tolerability of intra...
Status
Completed
Location
Southeast Retina Center
Start Date
2011-09
Trial ID
NCT01469156
Treatments Being Tested
The purpose of this study is to evaluate the effects of intravitreal Lucent...
Status
Completed
Location
Dept. of ophthalmology, Kyung Hee University Medical Center
Start Date
2008-12
Trial ID
NCT00942864
Treatments Being Tested
Ranibizumab has proven to be of benefit to improve the perfusion in the ret...
Status
Completed
Location
New England Retina Associates
Start Date
2010-07
Trial ID
NCT01251978
Treatments Being Tested